Serious but rare adverse events include pancreatitis, gallbladder disease, acute kidney injury, and hypersensitivity reactions
The Semaglutide Patent Puzzle: Evergreening and the Uphill Battle for Indian Generics Post-2026 Semaglutide, Novo Nordisks blockbuster GLP-1 receptor agonist marketed as Ozempic and Wegovy, has revolutionized the management of type 2 diabetes and obesity
Anti-inflammatory cytokine expression: The peptide shifts cytokine profiles toward anti-inflammatory patterns, reducing chronic inflammation that delays healing
Lu CW, Yang KC, Chang HH, Lee LT, Chen CY, Huang KC
Beans and Pulses Beans and pulses are rich in both fibre and protein, making them excellent natural GLP-1 boosters
For more lab tips, company updates, and insights into the world of peptide research, make sure you're following our page on Facebook